SEC CIK 918923
BIOTECHNOLOGY VALUE FUND L P
Reported ownership across 10 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CRISview stock → | 7,692,716 | 2009-04-27 |
| CYTKview stock → | 3,811,271 | 2020-12-09 |
| NBIXview stock → | 3,527,700 | 2011-10-12 |
| RGENview stock → | 2,765,050 | 2009-07-07 |
| CTMXview stock → | 2,164,406 | 2020-12-18 |
| VSTMview stock → | 994,353 | 2022-01-25 |
| RIGLview stock → | 646,559 | 2013-11-19 |
| LGNDview stock → | 230,125 | 2014-03-25 |
| XENEview stock → | 216,694 | 2018-03-27 |
| CBIOview stock → | 62,383 | 2025-06-13 |
Position History — CYTK
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CYTK
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2020-12-09 | Open-market sale | 239,274 | $18.00 | 3,811,271 |
| 2020-12-09 | Open-market sale | 25,486 | $18.00 | 463,244 |
| 2020-12-09 | Open-market sale | 166,194 | $18.00 | 2,760,185 |
| 2020-11-24 | — | — | — | 2,926,379 |
| 2020-11-24 | — | — | — | 488,730 |
| 2020-11-24 | — | — | — | 4,050,545 |
| 2020-11-20 | J (derivative) | 93 | $0.00 | 0 |
| 2020-11-12 | — | — | — | 2,777,320 |
| 2020-11-12 | — | — | — | 465,924 |
| 2020-11-12 | — | — | — | 3,822,766 |
| 2020-02-13 | Open-market sale | 510,793 | $15.79 | 2,350,829 |
| 2020-02-13 | Open-market sale | 486,344 | $15.79 | 3,131,432 |
| 2020-02-13 | Open-market sale | 74,893 | $15.79 | 424,419 |
| 2019-12-11 | Open-market buy | 8,506 | $9.52 | 499,312 |
| 2019-12-11 | Open-market buy | 49,804 | $9.52 | 2,861,622 |
| 2019-12-11 | Open-market buy | 60,103 | $9.52 | 3,617,776 |
| 2019-12-10 | Open-market buy | 15,030 | $9.40 | 490,806 |
| 2019-12-10 | Open-market buy | 95,100 | $9.40 | 2,811,818 |
| 2019-12-10 | Open-market buy | 113,529 | $9.40 | 3,557,673 |
| 2019-12-09 | — | — | — | 475,776 |
| 2019-12-09 | — | — | — | 3,444,144 |
| 2019-12-09 | — | — | — | 2,716,718 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.